TP53 and cancer: In short, these observations confirm that the anti-proliferative effect of NTAPP is highly preferential toward p53-deficient cancer cells and strongly suggest that NTAPP would be an efficient therapy in cancer cells resistant to γ-irradiation or chemotherapeutic agents due to the lack of functional p53.